
Chih-Yi Liao, MD, discusses the value of molecular testing in biliary tract carcinoma.

Your AI-Trained Oncology Knowledge Connection!


Chih-Yi Liao, MD, discusses the value of molecular testing in biliary tract carcinoma.

Chih-Yi Liao, MD, discusses key considerations for the selection of single-agent vs combination regimens in frontline metastatic hepatocellular carcinoma.

Chih-Yi Liao, MD, discusses outcomes reported with ivosidenib in patients with advanced cholangiocarcinoma.